WHA68: Global Vaccine Plan Lagging; New Proposal To Lower Prices

68th World Health Assembly Committee A

An assessment of the World Health Organization Global Vaccine Action Plan aimed at delivering vaccination to all and boosting research into new vaccines found implementation to be “far off-track” in some areas. Today at the World Health Assembly, Libya put forward a new proposal at the Assembly to reduce vaccine prices and increase availability in developing countries.

World Health Assembly Opens: Time Of Change At WHO; G-7 Involved

German Chancellor Angela Merkel speaks at WHA 68

“The Ebola outbreak shook this organization to its core,” World Health Organization Director General Margaret Chan said in opening the WHO’s annual assembly today. And the need to better construct the world’s emergency response systems has the biggest economies on the podium, with German Chancellor Angela Merkel speaking as chair of the Group of 7.

WHO Leads Effort To Build R&D Roadmap For Future Epidemics

Panel Chair Barbara Stocking, photo credit John Zaracostas

The World Health Organization is working to learn from the fast response on research and development for Ebola that led to effective treatments in a short time. It hopes that this changes the way R&D for emergency vaccines is done forever.

Ebola R&D, Antibiotic Resistance, Neglected Diseases Among Issues At This Year’s World Health Assembly

DSCN1032

The annual World Health Assembly opens next week with a focus on antimicrobial resistance, the Ebola outbreak, and research and development. Other subject of interests will be World Health Organization engagement with outside stakeholders, such as non-governmental organisations and the private sector, and a potential pooled fund for research and development for neglected diseases.

In ‘Huge’ Move, WHO Adds Key Hepatitis C, Cancer, TB Drugs To Essential Medicines List

happy crowd africa

The World Health Organization today published its updated Model List of Essential Medicines, including high-priced new treatments for hepatitis C, cancers and multi-drug resistant tuberculosis (MDR-TB) that were quickly applauded by the public health advocacy community.

Pharma Offers View On How To Slow Antimicrobial Resistance, Boost Research

Bacteria

the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) provided its recommendations on how to slow down antimicrobial resistance and boost antibiotic research and development. In addition, the association organised a forum on the subject today.

WHO: Too Few Countries Fighting Antimicrobial Resistance; Global Action Plan Advocates Equitable Access

Antibiotics

The World Health Organization released a report today on countries’ response to the global declining effect of antibiotics on bacteria and microbes, heightened by overuse or misuse of those products. Next month the World Health Assembly will consider a draft global action plan to fight the problem, which includes suggestions for sustainable investment in the area such as de-linking research from price and sales, as well as equitable access to new products.

Open, Online Database Of Clinical Trials Planned

open trials

A newly announced project will create an open, online database of information about the clinical research trials worldwide. The initiative, called Open Trials, will be directed by Ben Goldacre, an internationally known author (“Bad Science”) and advocated for clinical transparency. As announced by Open Knowledge yesterday, Open Trials “will aggregate information from a wide variety […]

WHO Reviews Its Essential Medicines List; Some New Candidates Under Patent

essential meds

The World Health Organization is reviewing its list of essential medicines this week. Over 70 candidate medicines are expected to be assessed by an Expert Committee. Some of those medicines are under patent and highly priced, which poses an accessibility challenge.

WHO Opens Its Database Of Medicines Side Effects To The Public

safe medicines

The World Health Organization has announced that its Global Medicines Safety Database is now open to the general public. The database named VigiAccess can now be accessed on any computer or smartphone in the world.